CONTINUE TO SITE >

OR WAIT 15 SECS

Cardiovascular Clinical Consult Diabetes Generics Gut Health Heart Health Immunization Migraine Oncology Respiratory Shingles Technology ThoughtSpot 2020

Cardiovascular Clinical Consult DiabetesGenericsGut HealthHeart HealthImmunizationMigraineOncologyRespiratoryShinglesTechnologyThoughtSpot 2020

Clinical

View More Anticoagulants Autoimmune Diseases Biosimilars CBD COPD Management Coronavirus Dermatology Diabetes Generics Gut Health Heart Health Immunization Influenza Oncology Pain Management Pediatrics Respiratory Shingles

AnticoagulantsAutoimmune DiseasesBiosimilarsCBDCOPD ManagementCoronavirusDermatologyDiabetesGenericsGut HealthHeart HealthImmunizationInfluenzaOncologyPain ManagementPediatricsRespiratoryShingles

News

All News Association News Clinical News Legal News Managed Care News New Products Technology Viewpoints

All NewsAssociation NewsClinical NewsLegal NewsManaged Care NewsNew ProductsTechnologyViewpoints

Media

Expert Interviews Medical World News Podcasts

Expert InterviewsMedical World NewsPodcasts

Practice Type

Chain Pharmacy Community Practice Health Systems

Chain PharmacyCommunity PracticeHealth Systems

Conferences

Conference Coverage Conference Listing

Conference CoverageConference Listing

Phase IV filgrastim study shows drug lives up to expectations

September 1, 2003

Amgen's filgrastim delivers what it promises in a phase IV study